http://orcid.org/0000-0002-5400-4491
Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Farheen Fatima Qizilbash, Ali Sartaj, Zufika Qamar, Shobhit Kumar, Mohammad Imran, Yousuf Mohammed, Javed Ali, Sanjula Baboota & Asgar Ali. (2023) Nanotechnology revolutionises breast cancer treatment: harnessing lipid-based nanocarriers to combat cancer cells. Journal of Drug Targeting 31:8, pages 794-816.
Read now
Read now
Nasrul Wathoni, Lisa Efriani Puluhulawa, I Made Joni, Muchtaridi Muchtaridi, Ahmed Fouad Abdelwahab Mohammed, Khaled M. Elamin, Tiana Milanda & Dolih Gozali. (2022) Monoclonal antibody as a targeting mediator for nanoparticle targeted delivery system for lung cancer. Drug Delivery 29:1, pages 2959-2970.
Read now
Read now
Yumeng Wei, Ke Li, Wenmei Zhao, Yingmeng He, Hongping Shen, Jiyuan Yuan, Chao Pi, Xiaomei Zhang, Mingtang Zeng, Shaozhi Fu, Xinjie Song, Robert J Lee & Ling Zhao. (2022) The Effects of a Novel Curcumin Derivative Loaded Long-Circulating Solid Lipid Nanoparticle on the MHCC-97H Liver Cancer Cells and Pharmacokinetic Behavior. International Journal of Nanomedicine 17, pages 2225-2241.
Read now
Read now
Articles from other publishers (30)
Isidore A. Egebe & Kamalinder K. Singh. 2023. Drug and Therapy Development for Triple Negative Breast Cancer. Drug and Therapy Development for Triple Negative Breast Cancer
249
272
.
Pankaj Kumar, Bharti Mangla, Shamama Javed, Waquar Ahsan, Pankaj Musyuni, Durgaramani Sivadasan, Saad S. Alqahtani & Geeta Aggarwal. (2023) A review of nanomaterials from synthetic and natural molecules for prospective breast cancer nanotherapy. Frontiers in Pharmacology 14.
Crossref
Crossref
Salma T. Rafik, Jayant S. Vaidya, Alexander J. MacRobert & Elnaz Yaghini. (2023) Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies. Journal of Clinical Medicine 12:7, pages 2648.
Crossref
Crossref
Zoya MalikRabea Parveen, Sageer Abass, Mohammad Irfan Dar, Syed Akhtar Husain & Sayeed Ahmad. (2022) Receptor-Mediated Targeting in Breast Cancer through Solid Lipid Nanoparticles
and Its Mechanism. Current Drug Metabolism 23:10, pages 800-817.
Crossref
Crossref
Abdul Qadeer, Hanif Ullah, Muhammad Sohail, Sher Zaman Safi, Abdur Rahim, Tawfik A Saleh, Safia Arbab, Petr Slama & Pavel Horky. (2022) Potential application of nanotechnology in the treatment, diagnosis, and prevention of schistosomiasis. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Abhishek Kanugo, Rupesh K. Gautam & Mohammad Amjad Kamal. (2022) Recent Advances of Nanotechnology in the Diagnosis and Therapy of Triple-
Negative Breast Cancer (TNBC). Current Pharmaceutical Biotechnology 23:13, pages 1581-1595.
Crossref
Crossref
Kaliyaperumal Rekha, Nalok Dutta, Muthu Thiruvengadam, Mohammad Ali Shariati, Muhammad Usman Khan, Muhammad Usman, Mihir Bhatta, Kunal Ghosh, Shaheer Arif & Muhammad Naeem. 2022. Nanomaterials in Clinical Therapeutics. Nanomaterials in Clinical Therapeutics
441
458
.
Yogesh Sutar, Sunna Nabeela, Shakti Singh, Abdullah Alqarihi, Norma Solis, Teklegiorgis Ghebremariam, Scott Filler, Ashraf S. Ibrahim, Abhijit Date & Priya Uppuluri. (2022) Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis. PLOS Biology 20:8, pages e3001762.
Crossref
Crossref
Rahul Kumar, Daphika S. Dkhar, Rohini Kumari, Divya, Supratim Mahapatra, Vikash Kumar Dubey & Pranjal Chandra. (2022) Lipid based nanocarriers: Production techniques, concepts, and commercialization aspect. Journal of Drug Delivery Science and Technology 74, pages 103526.
Crossref
Crossref
Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Sanjay Singh, Pradeep Kumar, Pradeep Kumar Bolla, Dinesh Kumar & Ashish Kumar Agrawal. (2022) Emergence of Nanotechnology as a Powerful Cavalry against Triple-Negative Breast Cancer (TNBC). Pharmaceuticals 15:5, pages 542.
Crossref
Crossref
Priti Tagde, Agnieszka Najda, Kalpana Nagpal, Giriraj T. Kulkarni, Muddaser Shah, Obaid Ullah, Sebastian Balant & Md. Habibur Rahman. (2022) Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. International Journal of Molecular Sciences 23:5, pages 2856.
Crossref
Crossref
Heba A. Gad, Reham S. Elezaby, Mai Mansour & Rania M. Hathout. 2022. Nanoengineering of Biomaterials. Nanoengineering of Biomaterials
107
143
.
Srushti Tambe, Sabya Sachi Das, Neeru Singh, Priya Ranjan Prasad Verma, Purnima Amin & Sandeep Kumar Singh. 2022. Hormone Related Cancer Mechanistic and Nanomedicines. Hormone Related Cancer Mechanistic and Nanomedicines
219
238
.
Sai Kiran S.S. Pindiprolu, Harani Avasarala & Sathis Kumar Dinakaran. (2021) Phenylboronic acid modified lipid nanocarriers mediated co-delivery of immunocytokine TRAIL and gamma-secretase inhibitor to triple negative breast cancer cells and cancer stem cells. Medical Hypotheses 157, pages 110716.
Crossref
Crossref
Ujjwala KANDEKAR & Rohini PUJARİ. (2021) Nanocarrier based precise approaches for anticancer agents in treatment of breast cancer.. Hacettepe University Journal of the Faculty of Pharmacy.
Crossref
Crossref
Ameeduzzafar Zafar, Nabil K. Alruwaili, Syed Sarim Imam, Khalid Saad Alharbi, Muhammad Afzal, Nasser Hadal Alotaibi, Mohd Yasir, Mohammed Elmowafy & Sultan Alshehri. (2021) Novel nanotechnology approaches for diagnosis and therapy of breast, ovarian and cervical cancer in female: A review. Journal of Drug Delivery Science and Technology 61, pages 102198.
Crossref
Crossref
Devasena T.Devasena T.. 2021. Nanotechnology-COVID-19 Interface. Nanotechnology-COVID-19 Interface
71
114
.
Ruchika, Rakesh Kumar Dhritlahre & Ankit Saneja. 2021. Sustainable Agriculture Reviews 56. Sustainable Agriculture Reviews 56
67
85
.
Sai Kiran S. S. Pindiprolu, Praveen Thaggikuppe Krishnamurthy, Pavan Kumar Chintamaneni, V. V. V. Ravi Kiran Ammu & Kusuma Kumari Garikapati. 2021. Cancer Nanotheranostics. Cancer Nanotheranostics
175
200
.
Jamal Mohammadian, Shiva Mahmoudi, Pirouz Pourmohammad, Mohammad Pirouzpanah, Fatemeh Salehnia, Nazila Fathi Maroufi, Nasser Samadi & Mehdi Sabzichi. (2020) Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 393:12, pages 2315-2323.
Crossref
Crossref
Mamta Kumari, Praveen T. Krishnamurthy, Sai kiran S. S. PinduproluPiyongsola Sola. (2020) DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment. Advanced Pharmaceutical Bulletin 11:4, pages 618-623.
Crossref
Crossref
Arpit Bhargava, Dinesh Kumar Mishra, Rajnarayan Tiwari, Nirmal Kumar Lohiya, Irina Yu Goryacheva & Pradyumna Kumar Mishra. (2020) Immune cell engineering: opportunities in lung cancer therapeutics. Drug Delivery and Translational Research 10:5, pages 1203-1227.
Crossref
Crossref
Mamta Kumari, Praveen Thaggikuppe Krishnamurthy & Piyong Sola. (2020) Targeted Drug Therapy to Overcome Chemoresistance in Triple-negative Breast Cancer. Current Cancer Drug Targets 20:8, pages 559-572.
Crossref
Crossref
Sara Cunha, Cláudia Pina Costa, João Nuno Moreira, José Manuel Sousa Lobo & Ana Catarina Silva. (2020) Using the quality by design (QbD) approach to optimize formulations of lipid nanoparticles and nanoemulsions: A review. Nanomedicine: Nanotechnology, Biology and Medicine 28, pages 102206.
Crossref
Crossref
Sai Kiran SS Pindiprolu, Praveen T Krishnamurthy, Venkata Rao Ghanta & Pavan Kumar Chintamaneni. (2020) Phenyl boronic acid-modified lipid nanocarriers of niclosamide for targeting triple-negative breast cancer. Nanomedicine 15:16, pages 1551-1565.
Crossref
Crossref
Milad Ashrafizadeh, Zahra Ahmadi, Niranjan G. Kotla, Elham Ghasemipour Afshar, Saeed Samarghandian, Ali Mandegary, Abbas Pardakhty, Reza Mohammadinejad & Gautam Sethi. (2019) Nanoparticles Targeting STATs in Cancer Therapy. Cells 8:10, pages 1158.
Crossref
Crossref
Mantosh Kumar Singh, Sai Kiran S. S. Pindiprolu, Bharat Kumar Reddy Sanapalli, Vidyasrilekha Yele & G. N. K. Ganesh. (2019)
Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer:
in vitro
studies
. RSC Advances 9:43, pages 24987-24994.
Crossref
Crossref
Wei Peng, Dan He, Bin Shan, Jun Wang, Wenwen Shi, Wenyuan Zhao, Zhenzi Peng, Qingxi Luo, Minghao Duan, Bin Li, Yuanda Cheng, Yeping Dong, Faqing Tang, Chunfang Zhang & Chaojun Duan. (2019) LINC81507 act as a competing endogenous RNA of miR-199b-5p to facilitate NSCLC proliferation and metastasis via regulating the CAV1/STAT3 pathway. Cell Death & Disease 10:7.
Crossref
Crossref
Beatriz García-Pinel, Cristina Porras-Alcalá, Alicia Ortega-Rodríguez, Francisco Sarabia, Jose Prados, Consolación Melguizo & Juan M. López-Romero. (2019) Lipid-Based Nanoparticles: Application and Recent Advances in Cancer Treatment. Nanomaterials 9:4, pages 638.
Crossref
Crossref
Eerdunduleng Eerdunduleng. (2019) circ-LDLRAD3 regulates cell proliferation, migration and invasion of pancreatic cancer by miR-876-3p/STAT3. Clinical Surgery Research Communications 1:1, pages 08-16.
Crossref
Crossref